Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
PTCHF PURETECH HEALTH PLC
3.130-0.010-0.32%
Close
02/07 16:00 ET
High
3.130
Open
3.130
Turnover
701.12
Low
3.130
Pre Close
3.140
Volume
224.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Short Interest in PureTech Health Plc (NASDAQ:PRTC) Increases By 100.0%
PureTech Health plc (NASDAQ:PRTC – Get Rating) was the target of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 400 share
PureTech Health Plc (NASDAQ:PRTC) Sees Significant Decline in Short Interest
PureTech Health plc (NASDAQ:PRTC – Get Rating) saw a significant decrease in short interest during the month of December. As of December 30th, there was short interest totalling 200 shares, a decrea
PureTech Health PLC (ADR) Trading Halted, Volatility Trading Pause
Short Interest in PureTech Health Plc (OTCMKTS:PTCHF) Drops By 45.7%
PureTech Health plc (OTCMKTS:PTCHF – Get Rating) saw a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 86,400 shares, a de
Short Interest in PureTech Health Plc (NASDAQ:PRTC) Declines By 63.6%
PureTech Health plc (NASDAQ:PRTC – Get Rating) saw a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 400 shares, a decrease o
PureTech Health Plc (OTCMKTS:PTCHF) Short Interest Up 26.3% in November
PureTech Health plc (OTCMKTS:PTCHF – Get Rating) was the recipient of a large increase in short interest during the month of November. As of November 30th, there was short interest totalling 159,100
PureTech Health Plc (NASDAQ:PRTC) Short Interest Update
PureTech Health plc (NASDAQ:PRTC – Get Rating) was the target of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 600 shares,
Equities Analysts Issue Forecasts for PureTech Health Plc's FY2022 Earnings (NASDAQ:PRTC)
PureTech Health plc (NASDAQ:PRTC – Get Rating) – Stock analysts at Jefferies Financial Group issued their FY2022 EPS estimates for shares of PureTech Health in a report issued on Thursday, October
Short Interest in PureTech Health Plc (NASDAQ:PRTC) Drops By 89.4%
PureTech Health plc (NASDAQ:PRTC – Get Rating) saw a significant drop in short interest in August. As of August 31st, there was short interest totalling 500 shares, a drop of 89.4% from the August 1
Short Interest in PureTech Health Plc (NASDAQ:PRTC) Expands By 30.6%
PureTech Health plc (NASDAQ:PRTC – Get Rating) was the target of a significant growth in short interest in August. As of August 15th, there was short interest totalling 4,700 shares, a growth of 30.
Company Overview
More
PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and Others. The Internal segment focuses on immunological, fibrotic, and lymphatic system mechanisms. The Controlled Founded Entities segment is composed of the group’s subsidiaries that are currently consolidated operational subsidiaries that either have or have plans to hire independent management teams and currently have already raised, or are currently in the process of raising, third-party dilutive capital. The Non-Controlled Founded Entities segment includes companies wherein the group no longer holds majority voting control as a shareholder and no longer has the right to elect a majority of the members of the subsidiaries’ Board of Directors. The Parent Company and Other segment represents activities that are not directly attributable to the operating segments, such as the activities of the parent, corporate support functions and certain research and development support functions that are not directly attributable to a strategic business segment as well as the elimination of intercompany transactions. The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.
CEO： Ms. Daphne Zohar
Market： Pink Market
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet